Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Suspension Authority Limits Peanut Recall, But FSMA Remains Grounded

This article was originally published in The Tan Sheet

Executive Summary

In a series of interviews, food safety experts weigh in on why the food and nutritional products industry still has work to do with the Food Safety Modernization Act not yet implemented, as illustrated by the recent salmonella contamination of peanut ingredients from Sunland Inc.

You may also be interested in...



ConAgra Pays Salmonella Fine: Health And Wellness Industry News Roundup

ConAgra Grocery pays largest food safety fine; Prop 65 office director named; and $10m funding round for REBBL.

Mandatory, Voluntary Recalls Distress Supplement Firms

Because a consent decree stipulated FDA could order Kabco Pharmaceuticals to recall products if the firm was found in violation, the enforcement did not emanate from the agency’s mandatory recall authority. Purity First Products, meanwhile, argues that FDA wrongly claimed the firm refused to conduct a recall.

Mandatory, Voluntary Recalls Distress Supplement Firms

Because a consent decree stipulated FDA could order Kabco Pharmaceuticals to recall products if the firm was found in violation, the enforcement did not emanate from the agency’s mandatory recall authority. Purity First Products, meanwhile, argues that FDA wrongly claimed the firm refused to conduct a recall.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS106148

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel